63 related articles for article (PubMed ID: 8335950)
1. Transendothelial migration activity of lymphokine-activated killer (LAK) cells.
Kitayama J; Juji T; Atomi Y; Kuroda A; Muto T; Kobayashi M; Mitsui Y; Minami M
J Immunol; 1993 Aug; 151(3):1663-72. PubMed ID: 8335950
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
3. Characterization of transendothelial migratory lymphokine-activated killer cells.
Nakano K; Eura M; Chikamatsu K; Masuyama K; Ishikawa T
Jpn J Cancer Res; 1996 Apr; 87(4):395-400. PubMed ID: 8641971
[TBL] [Abstract][Full Text] [Related]
4. Decreased susceptibility of lined human gliosarcoma cells to lymphokine-activated killer cell cytolysis by gamma-interferon treatment.
Miyatake S; Kikuchi H; Oda Y; Nishioka T; Takahashi J; Kondoh S; Matsumoto M; Yamasaki T; Iwasaki K; Aoki T
Cancer Res; 1990 Feb; 50(3):596-600. PubMed ID: 2137025
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
6. Toxic effects of interleukin-2-activated lymphocytes on vascular endothelial cells.
Amador JF; Vazquez AM; Cabrera L; Barral AM; Gendelman R; Jondal M
Nat Immun Cell Growth Regul; 1991; 10(4):207-15. PubMed ID: 1910152
[TBL] [Abstract][Full Text] [Related]
7. Lysis of endothelial cells by autologous lymphokine-activated killer cells.
Kitayama J; Tsuno N; Yasuhara H; Nagawa H; Kimura W; Kuroda A; Shibata Y; Juji T; Muto T
Cancer Immunol Immunother; 1994 May; 38(5):317-22. PubMed ID: 8162614
[TBL] [Abstract][Full Text] [Related]
8. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Falk CS; Noessner E; Weiss EH; Schendel DJ
Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
[TBL] [Abstract][Full Text] [Related]
9. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
Wu R; Coleman N; Stanley M
Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
[TBL] [Abstract][Full Text] [Related]
10. Induction of transendothelial migration in normal and malignant human T lymphocytes.
Hauzenberger D; Hultenby K; Sumitran S; Ruegg C; Klominek J
Anticancer Res; 2000; 20(4):2601-11. PubMed ID: 10953332
[TBL] [Abstract][Full Text] [Related]
11. Increased transendothelial migration of scleroderma lymphocytes.
Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
[TBL] [Abstract][Full Text] [Related]
12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer.
Lou J; Gasche Y; Zheng L; Giroud C; Morel P; Clements J; Ythier A; Grau GE
Lab Invest; 1999 Aug; 79(8):1015-25. PubMed ID: 10462039
[TBL] [Abstract][Full Text] [Related]
14. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
15. Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells.
Piali L; Albelda SM; Baldwin HS; Hammel P; Gisler RH; Imhof BA
Eur J Immunol; 1993 Oct; 23(10):2464-71. PubMed ID: 8405046
[TBL] [Abstract][Full Text] [Related]
16. A lymphokine-activated killer (LAK)-resistant cell line, and low expression of adhesion molecules LFA-3 and VCAM-1 on its cell surface.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(5):263-9. PubMed ID: 9802061
[TBL] [Abstract][Full Text] [Related]
17. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
Gwin JL; Gercel-Taylor C; Taylor DD; Eisenberg B
J Surg Res; 1996 Jan; 60(1):129-36. PubMed ID: 8592403
[TBL] [Abstract][Full Text] [Related]
18. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking.
Hauzenberger E; Klominek J; Holgersson J
Eur J Immunol; 2004 Apr; 34(4):1154-63. PubMed ID: 15048727
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.
Okita R; Yamaguchi Y; Emi A; Matsuura K; Toge T
Oncol Rep; 2007 Jun; 17(6):1429-35. PubMed ID: 17487401
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
Baum D; Yaron R; Yellin MJ
Cell Immunol; 1998 Nov; 190(1):12-22. PubMed ID: 9826442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
